Effectiveness of Two-Year Clopidogrel + Aspirin in Abolishing the Risk of Very Late Thrombosis After Drug-Eluting Stent Implantation (from the TYCOON [Two-Year ClOpidOgrel Need] Study)

« Previous Next »American Journal of Cardiology
Volume 104, Issue 10 , Pages 1357-1361, 15 November 2009

Gaetano Tanzilli, MD
- Department of Heart and Great Vessels “Attilio Reale,” La Sapienza University, Rome, Italy
Cesare Greco, MD
- Department of Heart and Great Vessels “Attilio Reale,” La Sapienza University, Rome, Italy
Francesco Pelliccia, MD, PhD
- Department of Heart and Great Vessels “Attilio Reale,” La Sapienza University, Rome, Italy
- Department of Cardiovascular Medicine, San Filippo Neri Hospital, Rome, Italy
- Corresponding author: Tel: 39-348-339-2006; fax: 39-06-330-62516
Vincenzo Pasceri, MD, PhD
- Department of Cardiovascular Medicine, San Filippo Neri Hospital, Rome, Italy
Francesco Barillà, MD
- Department of Heart and Great Vessels “Attilio Reale,” La Sapienza University, Rome, Italy
Vincenzo Paravati, MD
- Department of Heart and Great Vessels “Attilio Reale,” La Sapienza University, Rome, Italy
Gaetano Pannitteri, MD
- Department of Heart and Great Vessels “Attilio Reale,” La Sapienza University, Rome, Italy
Carlo Gaudio, MD
- Department of Heart and Great Vessels “Attilio Reale,” La Sapienza University, Rome, Italy
Enrico Mangieri, MD
- Department of Heart and Great Vessels “Attilio Reale,” La Sapienza University, Rome, Italy